The overall ratings of seven medical devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
BIOLASE, Inc. (BIOL) is on the decline this week, earning a D (“sell”) after receiving a C (“hold”) last week. BIOLASE develops, manufactures, and markets lasers systems for dental and medical applications and procedures in the United States and internationally. In Portfolio Grader’s specific subcategories of Earnings Revisions, Equity and Sales Growth, BIOL also gets an F. As of Feb. 3, 2014, 13.7% of outstanding BIOLASE, Inc. shares were held short. To get an in-depth look at BIOL, get Portfolio Grader’s complete analysis of BIOL stock.
This week, Inspiremd, Inc.’s (NSPR) rating worsens to a D from the company’s C rating a week ago. The stock gets F’s in Equity and Cash Flow. For a full analysis of NSPR stock, visit Portfolio Grader.
Abaxis, Inc. (ABAX) earns an F (“strong sell”) this week, moving down from last week’s grade of D (“sell”). Abaxis is engaged in the development, manufacture, marketing and sale of portable blood analysis systems for use in the human or veterinary patient-care setting. The stock receives F’s in Earnings Growth, Earnings Momentum, Earnings Revisions and Earnings Surprise. The stock price has fallen 5% over the past month, worse than the 1.3% decrease the Nasdaq has seen over the same period of time. As of Feb. 3, 2014, 10.9% of outstanding Abaxis, Inc. shares were held short. The trailing PE Ratio for the stock is 45.40. For more information, get Portfolio Grader’s complete analysis of ABAX stock.
Haemonetics Corporation (HAE) earns an F this week, moving down from last week’s grade of D. Haemonetics designs, manufactures, and markets automated blood processing systems. The stock’s trailing PE Ratio is 53.10. To get an in-depth look at HAE, get Portfolio Grader’s complete analysis of HAE stock.
This week, STERIS Corporation (STE) drops from a C to a D rating. STERIS provides products and services related to infection prevention and surgical procedures. For more information, get Portfolio Grader’s complete analysis of STE stock.
Alphatec Holdings, Inc. (ATEC) earns a D this week, falling from last week’s grade of C. Alphatec Holdings designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, primarily focusing on the aging spine in the United States and internationally. The stock gets F’s in Earnings Revisions and Equity. For a full analysis of ATEC stock, visit Portfolio Grader.
Syneron Medical Ltd’s (ELOS) rating weakens this week, dropping to a D versus last week’s C. Syneron Medical designs, develops, and markets aesthetic medical products based on proprietary Electro-Optical Synergy technologies. The stock also rates an F in Earnings Momentum. To get an in-depth look at ELOS, get Portfolio Grader’s complete analysis of ELOS stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
